Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Gerd Jomrich, Marlene Hollenstein, Maximilian John, Andreas Baierl, Matthias Paireder, Ivan Kristo, Aysegül Ilhan-Mutlu, Reza Asari, Matthias Preusser, Sebastian F. Schoppmann
Published Jan 8, 2018 · Vol. 9, No. 6 · pp. 6968-6976
Sanchareeka Dey, Sharda Kumari, Sarada Preeta Kalainayakan, James Campbell III, Poorva Ghosh, Heling Zhou, Keely E. FitzGerald, Maoping Li, Ralph P. Mason, Li Zhang, Li Liu
Published Dec 28, 2017 · Vol. 9, No. 3 · pp. 4090-4101
Michael D. West, Ivan Labat, Hal Sternberg, Dana Larocca, Igor Nasonkin, Karen B. Chapman, Ratnesh Singh, Eugene Makarev, Alex Aliper, Andrey Kazennov, Andrey Alekseenko, Nikolai Shuvalov, Evgenia Cheskidova, Aleksandr Alekseev, Artem Artemov, Evgeny Putin, Polina Mamoshina, Nikita Pryanichnikov, Jacob Larocca, Karen Copeland, Evgeny Izumchenko, Mikhail Korzinkin, Alex Zhavoronkov
Published Dec 28, 2017 · Vol. 9, No. 8 · pp. 7796-7811